CHATSWORTH, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, announced today that its Iris Diagnostics Division has been granted 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its iChem®VELOCITY™ Automated Urine Chemistry Analyzer and iRICELL® Urinalysis Workstation.
